Cerena Chen
Stock Analyst at Wells Fargo
(2.80)
# 1,729
Out of 5,113 analysts
5
Total ratings
100%
Success rate
37.81%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $161.58 | -66.58% | 1 | Sep 30, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $26.25 | +33.33% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $188.02 | -12.24% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $161.58
Upside: -66.58%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $26.25
Upside: +33.33%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $188.02
Upside: -12.24%